Search

Author/Creator Rath, T.

1. AB0545 Interferon Alpha2a versus Cyclosporin A for The Treatment of Severe Ocular Behcet's Disease – A Prospective, Randomised, Single Blind, National Multicenter Trial (INCYTOB). (15th July 2016)

Authors:
Kötter, I.; Vonthein, R.; Schoenfisch, B.; Xenitidis, T.; Doycheva, D.; Henes, J.; Stübiger, N.; Feist, E.; Heiligenhaus, A.; Rath, T.; Max, R.; Mackensen, F.; Altenburg, A.; Krause, L.; Zouboulis, C.; Blaschke, S.; Horn, M.; Neß, T.; Goldacker, S.; Deuter, C.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 75(2016)Supplement 2
Page Start:
1091
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. OC.14.3 FLAMINGO SET FOR THE ENDOSCOPIC TREATMENT OF BURIED BUMPER SYNDROME: MULTICENTRE, RETROSPECTIVE, COHORT STUDY. (1st October 2020)

Authors:
Costa, D.; Despott, E.J.; Woodward, J.; Kohout, P.; Rath, T.; Scovell, L.; Gee, I.; Hindryckx, P.; Forrest, E.; Jordan, D.; Hollywood, C.; Hearing, S.; Mohammed, I.; Cooney, R.; Sharma, H.; Zieno, Z.; Gooding, I.; Lazaridis, N.; Coppo, C.; Koukias, N.
Journal:
Digestive and liver disease
Issue:
Volume 52(2020)Supplement 2
Page Start:
S44
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. THU0379 REDUCTION OF ANTERIOR UVEITIS FLARES IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS FOLLOWING ONE YEAR OF TREATMENT WITH CERTOLIZUMAB PEGOL: 48-WEEK INTERIM RESULTS FROM A 96-WEEK OPEN-LABEL STUDY. (2nd June 2020)

Authors:
Van der Horst-Bruinsma, I.; Van Bentum, R.; Verbraak, F.; Rath, T.; Rosenbaum, J.; Misterska-Skora, M.; Hoepken, B.; Irvin-Sellers, O.; Vanlunen, B.; Bauer, L.; Rudwaleit, M.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 79(2020)Supplement 1
Page Start:
423
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗